Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 1
2009 2
2010 3
2012 1
2013 1
2015 4
2016 6
2017 1
2018 2
2019 2
2020 1
2021 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Olivera-Salguero R, Seguí E, Cejalvo JM, Oliveira M, Tolosa P, Vidal M, Malumbres M, Gavilá J, Saura C, Pernas S, López R, Margelí M, Balmaña J, Muñoz M, Blancas I, Boni V, Ciruelos E, Galve E, Perelló A, Sánchez-Bayona R, de la Cruz S, de la Hoya M, Galván P, Sanfeliu E, Gonzalez-Farre B, Sirenko V, Blanch-Torras A, Canes J, Masanas H, Olmos R, Forns M, Prat A, Casas A, Pascual T. Olivera-Salguero R, et al. Among authors: de la cruz s. Front Oncol. 2023 Apr 28;13:1151496. doi: 10.3389/fonc.2023.1151496. eCollection 2023. Front Oncol. 2023. PMID: 37188177 Free PMC article.
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study.
Arraras JI, Illarramendi JJ, Manterola A, de la Cruz S, Zarandona U, Ibañez B, Salgado E, Visus I, Barrado M, Teiejira L, Martinez MI, Martinez E, Vera R. Arraras JI, et al. Among authors: de la cruz s. Menopause. 2023 Jun 1;30(6):613-620. doi: 10.1097/GME.0000000000002178. Epub 2023 Apr 4. Menopause. 2023. PMID: 37022296
Quality of life of early-stage breast-cancer patients diagnosed with COVID-19 in the first three waves of the epidemic treated in the Spanish region of Navarre.
Arraras JI, Illarramendi JJ, Manterola A, Cruz S, Zarandona U, Ibañez B, Salgado E, Visus I, Barrado M, Teijeira L, Martinez E, Vera R. Arraras JI, et al. Among authors: cruz s. Psychooncology. 2023 May;32(5):730-740. doi: 10.1002/pon.6118. Epub 2023 Mar 17. Psychooncology. 2023. PMID: 36882856
Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies.
Mejías Sosa L, López-Janeiro Á, Córdoba Iturriagagoitia A, Sala P, Solans BP, Hato L, Inogés S, López-Díaz de Cerio A, Guillén-Grima F, Espinós J, De La Cruz S, Lozano MD, Idoate MA, Santisteban M. Mejías Sosa L, et al. Among authors: de la cruz s. Biomedicines. 2023 Jan 17;11(2):238. doi: 10.3390/biomedicines11020238. Biomedicines. 2023. PMID: 36830775 Free PMC article.
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group. Swain SM, et al. Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171426 Clinical Trial.
Corrigendum to "Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up" [Breast 41 (October 2018) 74-81].
Arraras JI, Manterola A, Illarramendi JJ, Asin G, de la Cruz S, Ibañez B, Galbete A, Salgado E, Zarandona U, Vera R, Dominguez MA, Martinez E. Arraras JI, et al. Among authors: de la cruz s. Breast. 2019 Feb;43:7. doi: 10.1016/j.breast.2018.10.003. Epub 2018 Oct 18. Breast. 2019. PMID: 30342259 No abstract available.
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Blanco-Luquin I, De La Cruz S, Aramendia A, Guerrero-Setas D. Martín-Sánchez E, et al. Among authors: de la cruz s. Clin Epigenetics. 2017 Jan 24;9:7. doi: 10.1186/s13148-016-0309-z. eCollection 2017. Clin Epigenetics. 2017. PMID: 28149335 Free PMC article.
28 results